Drug Stock Headed for Record Lows After Discounted Share Offering

Short sellers will likely be sidelined in today's trading

Managing Editor
Jul 27, 2018 at 9:13 AM
facebook X logo linkedin

Nabriva Therapeutics (NASDAQ:NBRV) stock is trading down 15.6% ahead of the open, after the Ireland-based biopharmaceutical firm priced its stock offering at roughly $50 million, or $2.75 per share. The is a discount to Thursday's close of $3.08, which was a record low at that time.

Should today's expected price action play out, it would have NBRV logging its worst day since May 21, when the stock tumbled over safety worries pertaining to Lefamulin, the company's pneumonia drug. Prior to today, the shares have given back more than 70% over the last 12 months, guided lower by their descending 20-week moving average.

Analysts have remained committed to the biopharma, though. All seven of the brokerages in coverage rate the stock a "strong buy," while the consensus 12-month price target of $17.64 is a 473% premium to last night's close. A round of bearish brokerage notes could pressure the stock even lower.

The shares could also encounter bigger headwinds, should short sellers continue ramping up their exposure to NBRV. Short interest surged 21.8% in the two most recent reporting periods to 1.20 million shares. However, this only represents a meager 4.8% of NBRV's total available float, indicating there is ample room aboard the bearish bandwagon. Regardless, shorts will likely be sidelined in today's trading, with the stock all but guaranteed a spot on the short-sale restricted list.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI